HARBOUR BIOMED
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.
HARBOUR BIOMED
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2016-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.harbourbiomed.com
Total Employee:
51+
Status:
Active
Contact:
+86-21-51370990
Email Addresses:
[email protected]
Total Funding:
312.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Mobile Non Scaleable Content Nginx Euro Microsoft Azure DNS PHP
Similar Organizations
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
I-Mab Biopharma
I-Mab is a dynamic and fast-growing global biotech company exclusively focused on developing innovative biologics.
IASO Biotherapeutics
IASO Biotherapeutics is a biopharmaceutical company focused on the development of cell therapies in the field of oncology.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
InventisBio
InventisBio is a clinical-stage biotech company dedicated to the research and development of innovative small-molecule drugs.
Lianchuang Biomedicine
Lianchuang Bio is a pharmaceutical company that offers R&D, production, and marketing of advanced pharmaceutical intermediates.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
TOT BIOPHARM
TOT BIOPHARM is a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative oncology drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-12-19 | Harbour Antibodies | Harbour Antibodies acquired by Harbour Biomed | N/A |
Investors List
Hudson Bay Capital Management
Hudson Bay Capital Management investment in Series C - Harbour Biomed
Greater Bay Area Homeland Development Fund
Greater Bay Area Homeland Development Fund investment in Series C - Harbour Biomed
Octagon Capital Partners
Octagon Capital Partners investment in Series C - Harbour Biomed
Country Garden
Country Garden investment in Series C - Harbour Biomed
OrbiMed
OrbiMed investment in Series C - Harbour Biomed
ShenZhen GTJA Investment Group
ShenZhen GTJA Investment Group investment in Series C - Harbour Biomed
SK Holdings
SK Holdings investment in Series B - Harbour Biomed
Zhejiang University
Zhejiang University investment in Series B - Harbour Biomed
Greater Bay Area Homeland Development Fund
Greater Bay Area Homeland Development Fund investment in Series B - Harbour Biomed
GIC
GIC investment in Series B - Harbour Biomed
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-14 | Harbour BioMed Appoints Dr. Humphrey Gardner as Chief Medical Officer |
| 2021-12-02 | Harbour BioMed Appoints Mr. Weihao Xu as Chief Strategy Officer |
| 2021-07-20 | Harbour BioMed Appoints Yingying Chen, PhD, as Chief Financial Officer |
Official Site Inspections
http://www.harbourbiomed.com Semrush global rank: 3.95 M Semrush visits lastest month: 3.16 K
Unable to get host informations!!!
